{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:48:47Z","timestamp":1769590127495,"version":"3.49.0"},"reference-count":53,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T00:00:00Z","timestamp":1447977600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Laryngol. Otol."],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0022215115002509_sec_a1\"><jats:title>Objective:<\/jats:title><jats:p>This systematic review aimed to establish that quinolones are as effective as aminoglycosides when used to treat chronic suppurative otitis media.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215115002509_sec_a2\"><jats:title>Method:<\/jats:title><jats:p>The review included good quality, randomised, controlled trials on human subjects, published in English, that compared topical aminoglycosides with topical quinolones for the treatment of chronic suppurative otitis media.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215115002509_sec_a3\"><jats:title>Results:<\/jats:title><jats:p>Nine trials met the criteria. Two studies showed a higher clinical cure rate in the quinolone group (93 per cent<jats:italic>vs<\/jats:italic>71 per cent,<jats:italic>p<\/jats:italic>= 0.04, and 76 per cent<jats:italic>vs<\/jats:italic>52 per cent,<jats:italic>p<\/jats:italic>= 0.009). Four studies showed no statistically significant difference in clinical outcome. A significant difference in microbiological clearance in favour of quinolones was shown in two studies (88 per cent<jats:italic>vs<\/jats:italic>30 per cent,<jats:italic>p<\/jats:italic>&lt; 0.001, and 88 per cent<jats:italic>vs<\/jats:italic>30 per cent,<jats:italic>p<\/jats:italic>&lt; 0.001).<\/jats:p><\/jats:sec><jats:sec id=\"S0022215115002509_sec_a4\"><jats:title>Conclusion:<\/jats:title><jats:p>Topical quinolones do not carry the same risk of ototoxicity as aminoglycosides. Furthermore, they are equal or more effective in treating chronic suppurative otitis media and when used as prophylaxis post-myringotomy. Topical quinolones should be considered a first-line treatment for these patients.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0022215115002509","type":"journal-article","created":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T08:03:05Z","timestamp":1448006585000},"page":"2-7","source":"Crossref","is-referenced-by-count":13,"title":["Why are ototopical aminoglycosides still first-line therapy for chronic suppurative otitis media? A systematic review and discussion of aminoglycosides versus quinolones"],"prefix":"10.1017","volume":"130","author":[{"given":"A S","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H A","family":"Elhassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E P","family":"Flook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2015,11,20]]},"reference":[{"key":"S0022215115002509_ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036226"},{"key":"S0022215115002509_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2008.10.001"},{"key":"S0022215115002509_ref34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.5694\/j.1326-5377.2007.tb01067.x","article-title":"Ototoxic ear drops with grommet and tympanic membrane perforations: a position statement","volume":"186","author":"Black","year":"2007","journal-title":"Med J Aust"},{"key":"S0022215115002509_ref35","article-title":"Use of ototoxic eardrops: a position statement from the New Zealand Society of Otolaryngology Head and Neck Surgery","volume":"120","author":"Gilbert","year":"2007","journal-title":"N Z Med J"},{"key":"S0022215115002509_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2003.12.007"},{"key":"S0022215115002509_ref46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/014556130708611s05","article-title":"Bacterial resistance to quinolone otic drops is nearly zero","volume":"86","author":"Poole","year":"2007","journal-title":"Ear Nose Throat J"},{"key":"S0022215115002509_ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-012-1924-8"},{"key":"S0022215115002509_ref43","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1995.01890120070014"},{"key":"S0022215115002509_ref15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.1998.00161.x"},{"key":"S0022215115002509_ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199907000-00015"},{"key":"S0022215115002509_ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-4486.2007.01532.x"},{"key":"S0022215115002509_ref49","unstructured":"Medicines and Healthcare Products Regulatory Agency. Apply for a licence to market a medicine in the UK. In: http:\/\/www.mhra.gov.uk\/Howweregulate\/Medicines\/Licensingofmedicines\/index.htm [20 August 2015]"},{"key":"S0022215115002509_ref23","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2009.30"},{"key":"S0022215115002509_ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7254.126"},{"key":"S0022215115002509_ref8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1017\/S0022215107001508","article-title":"Accurate consent for insertion and later removal of grommets","volume":"121","author":"Sood","year":"2007","journal-title":"J Laryngol Otol"},{"key":"S0022215115002509_ref36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"S0022215115002509_ref45","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.132.12.1294"},{"key":"S0022215115002509_ref28","first-page":"3","article-title":"Study to determine plasma levels of ciprofloxacin after the administration of ciprofloxacin 0.3% ear drops in children with diffuse otitis externa [in Spanish]","volume":"27","author":"Garc\u00eda-Monge","year":"1997","journal-title":"Pediatria Rural Y Extrahospitalaria"},{"key":"S0022215115002509_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(98)00049-1"},{"key":"S0022215115002509_ref20","doi-asserted-by":"publisher","DOI":"10.1002\/lary.21015"},{"key":"S0022215115002509_ref19","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200326060-00003"},{"key":"S0022215115002509_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2003.12.008"},{"key":"S0022215115002509_ref7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005608"},{"key":"S0022215115002509_ref10","volume-title":"Antibiotic Prophylaxis in Surgery","year":"2008"},{"key":"S0022215115002509_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2003.12.009"},{"key":"S0022215115002509_ref26","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31818b0c9c"},{"key":"S0022215115002509_ref17","doi-asserted-by":"publisher","DOI":"10.1002\/lary.22136"},{"key":"S0022215115002509_ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008512.pub2"},{"key":"S0022215115002509_ref27","first-page":"97","article-title":"Determination of plasma ciprofloxacin levels in children treated with topical ciprofloxacin 0.2% for tympanic perforation [in Spanish]","volume":"51","author":"Clar\u00f3s","year":"2000","journal-title":"Acta Otorrinolaringol Esp"},{"key":"S0022215115002509_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2008.08.005"},{"key":"S0022215115002509_ref11","first-page":"1056","article-title":"Aminoglycoside ear drops and ototoxicity","volume":"156","author":"Helal","year":"1997","journal-title":"CMAJ"},{"key":"S0022215115002509_ref24","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2008.559"},{"key":"S0022215115002509_ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004618.pub2"},{"key":"S0022215115002509_ref29","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1995.01890080048009"},{"key":"S0022215115002509_ref18","unstructured":"Medical Protection Society. Problems with eardrops. Casebook 2008. In: http:\/\/www.medicalprotection.org\/uk\/resources\/case-reports\/case-reports\/uk-problems-with-eardrops [20 August 2015]"},{"key":"S0022215115002509_ref42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.26719\/2001.7.1-2.26","article-title":"Topical ciprofloxacin versus topical gentamicin for chronic otitis media","volume":"7","author":"Nawasreh","year":"2001","journal-title":"East Mediterr Health J"},{"key":"S0022215115002509_ref51","unstructured":"Therapeutic Goods Administration. CILOXAN\u00ae (ciprofloxacin) 0.3 per cent Ear Drops. Australia 2014. In: https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent&id=CP-2010-PI-02301-3 [20 August 2015]"},{"key":"S0022215115002509_ref22","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200101000-00038"},{"key":"S0022215115002509_ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2003.12.010"},{"key":"S0022215115002509_ref33","volume-title":"Anti-infective Guidelines for Community-Acquired Infections","author":"Rosser","year":"2005"},{"key":"S0022215115002509_ref37","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archotol.1997.01900100031003","article-title":"Chronic otitis media treated topically with ciprofloxacin or tobramycin","volume":"123","author":"Fradis","year":"1997","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"S0022215115002509_ref38","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31816fca9d"},{"key":"S0022215115002509_ref39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5694\/j.1326-5377.2003.tb05496.x","article-title":"Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children: a community-based, multicentre, double blind randomised controlled trial","volume":"179","author":"Couzos","year":"2003","journal-title":"Med J Aust"},{"key":"S0022215115002509_ref41","doi-asserted-by":"publisher","DOI":"10.1067\/mhn.2000.107888"},{"key":"S0022215115002509_ref47","volume-title":"British National Formulary (BNF) 68","year":"2014"},{"key":"S0022215115002509_ref50","unstructured":"Therapeutic Goods Administration. CILOQUIN\u00ae (ciprofloxacin) 0.3 per cent Ear Drops. Australia 2013. In: https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent&id=CP-2010-PI-02436-3 [20 August 2015]"},{"key":"S0022215115002509_ref53","unstructured":"US Food and Drug Administration. FDA approved drug products. Search: Ciprofloxacin. In: http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm [10 March 2015]"},{"key":"S0022215115002509_ref52","unstructured":"Alcon Canada. Product Monograph: Ciprodex. Health Canada 2004. In: http:\/\/webprod5.hc-sc.gc.ca\/dpd-bdpp\/start-debuter.do?lang=eng [31 August 2015]"},{"key":"S0022215115002509_ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200209000-00015"},{"key":"S0022215115002509_ref44","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5876(01)00552-3"},{"key":"S0022215115002509_ref21","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2033"},{"key":"S0022215115002509_ref48","unstructured":"General Medical Council. Prescribing guidance: Prescribing unlicensed medicines. In: http:\/\/www.gmc-uk.org\/guidance\/ethical_guidance\/14327.asp [20 August 2015]"},{"key":"S0022215115002509_ref40","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100133523"}],"container-title":["The Journal of Laryngology &amp; Otology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0022215115002509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T17:19:26Z","timestamp":1653585566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0022215115002509\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,20]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0022215115002509"],"URL":"https:\/\/doi.org\/10.1017\/s0022215115002509","relation":{},"ISSN":["0022-2151","1748-5460"],"issn-type":[{"value":"0022-2151","type":"print"},{"value":"1748-5460","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,20]]}}}